PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Healthcare reform in US • Impact of US healthcare reform on cancer testing industry PART 06: Reimbursement and coverage: An overview • Current scenario: Validating diagnostic tests • Reimbursement structure in US • Prevailing issues of reimbursement policies PART 07: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 08: Market segmentation by technology • Conventional testing • Genetic testing PART 09: Market segmentation by cancer type • Breast cancer • Lung cancer • Colorectal cancer • Prostate cancer • Cervical cancer • Other PART 10: Market drivers • High demand for personalized medicines • Changes in healthcare system • Rise in demand for POC testing • Increase in molecular testing PART 11: Impact of drivers PART 12: Market challenges • Shortage of accurate cancer testing kits • Regulatory issues • Lack of skilled technicians PART 13: Impact of drivers and challenges PART 14: Market trends • Use of bench-top mass spectrometer • Ready-to-use reagents PART 15: Vendor landscape • Competitive scenario • Key vendor analysis 2015 • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: US healthcare infrastructure before and after healthcare reform Exhibit 03: Positive and negative impact of US healthcare reform on market Exhibit 04: Reimbursement perspectives of healthcare entities Exhibit 05: Solid tumor testing market in US Exhibit 06: Solid tumor testing market in US 2015-2020 ($ billions) Exhibit 07: Five forces analysis Exhibit 08: Segmentation of solid tumor testing market in US by technology 2015 Exhibit 09: Segmentation of solid tumor testing market in US by technology 2020 Exhibit 10: Segmentation of solid tumor testing market in US by technology 2015-2020 Exhibit 11: Solid tumor conventional testing market in US 2015-2020 ($ billions) Exhibit 12: Solid tumor genetic testing market in US 2015-2020 ($ billions) Exhibit 13: Segmentation of solid tumor testing market in US by cancer type Exhibit 14: Segmentation of solid tumor testing market in US by cancer type 2015 Exhibit 15: Segmentation of solid tumor testing market in US by cancer type 2020 Exhibit 16: Segmentation of solid tumor testing market in US by cancer type 2015-2020 Exhibit 17: Solid tumor testing market in US for breast cancer 2015-2020 ($ billions) Exhibit 18: Solid tumor testing market in US for lung cancer 2015-2020 ($ billions) Exhibit 19: Solid tumor testing market in US for colorectal cancer 2015-2020 ($ billions) Exhibit 20: Solid tumor testing market in US for prostate cancer 2015-2020 ($ millions) Exhibit 21: Solid tumor testing market in US for cervical cancer 2015-2020 ($ millions) Exhibit 22: Solid tumor testing market in US for other cancers 2015-2020 ($ millions) Exhibit 23: Impact of drivers Exhibit 24: Impact of drivers and challenges Exhibit 25: Abbott Molecular: Key takeaways Exhibit 26: Agilent Technologies (Dako): Key takeaways Exhibit 27: Beckman Coulter: Key takeaways Exhibit 28: Roche Diagnostics: Key takeaways

Abbott Molecular, Agilent Technologies (Dako), Beckman Coulter, Roche Diagnostics, 20/20 GeneSystems, Adaptive Biotechnologies, Advanced Cell Diagnostics, Affymetrix, Agena Bioscience, Ambry Genetics, ApoCell, Avant Diagnostics, Biological Dynamics, Boditech Med, Becton, Dickinson and Company (BD), Biocare Medical, Bio-Rad Laboratories, Castle Biosciences, CDx Diagnostics, Celerus Diagnostics, Cancer Genetics, Caris Life Sciences, Clarient Diagnostic Services, DiaTech Oncology, Enzo Biochem, Epic Sciences, EDP Biotech, Eutropics Pharmaceuticals, Fujirebio Diagnostics, Genalyte, Hologic, Janssen Diagnostics, Myriad Genetics, Omnyx, OxfordGene Technology, Oncospire Genomics, OncoCyte, OvaGene Oncology, Pathway Genomics, Quest Diagnostics, QIAGEN, RiboMed Biotechnologies, Sequenom, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Tosoh Bioscience, TrimGen.